Microbot Medical Down 7.8% After White Diamond

Microbot Medical shares fell 7.8% on Thursday after White Diamond Research released a bearish report questioning its LIBERTY robotic system.
White Diamond set a $1 price target, disclosed a short position, and cited added $3‑4k per procedure costs with no reimbursement.
Surgeons reported the device adds time, lacks accuracy advantage, uses only .014" guidewires, and is disposable after single use.
Dr. Charles Briggs of Tampa General Hospital uses LIBERTY weekly, being the sole user among 15 vascular surgeons, highlighting limited adoption.